On December 10th Adobe (ADBE) reported Q4 earnings that beat estimates with revenues inline. The stock made a new high in the days that followed before retreating a little. It is now making a move …
Continue readingLast night on CNBC’s Fast Money we had a short little debate on how to properly assign an earnings multiple to a once highflying growth darling like Chipolte (CMG), once disaster hits. As I detailed …
Continue readingOn Friday’s Option’s Action on CNBC, my co-panelist Carter Worth made a fairly compelling case why shares of McDonald’s (MCD), one of the best performing stocks in the Dow Jones Industrial Average in 2015 could …
Continue readingOn July 20th, the day after Hasbro (HAS) reported Q2 earnings that beat on strength of sales of Jurassic World movie toys, the stock closed up 50% on the year, closing at a new all …
Continue readingRegular readers of Risk Reversal know that we are tried and true believers in technical analysis, despite rarely starting an idea with a chart, more commonly using charts as an input to an existing thesis. …
Continue readingLast night on CNBC’s Fast Money Carter Worth of Cornerstone Research laid out the case for buying the “Dogs of the Dow”. The strategy entails buying the worst performing stocks in the Dow Jones Industrial …
Continue readingQualcom (QCOM) stock has had a rough year and a half, topping out during the Summer of 2014 at $82 and steadily declining to recent lows around $46: A couple of weeks ago, when the …
Continue readingThe largest options trade on the tape today is an opening purchase of 100,000 of the FXI Jan 37 strike calls for 38 cents when the etf was $35.60, amounting to $3.8 million in premium. This trade …
Continue readingIn late November we bought Pfizer (PFE) stock and sold a January upside call (creating an over-write) after the stock sold off on the news of the long rumored merger with Allergen. Here was the …
Continue readingThe financial and mainstream press have had a field day with Martin Shkreli, the thirty something year old Pharma company CEO. In September he came under widespread scrutiny for raising the price of a highly …
Continue reading